In an unmanipulated haplo-SCT protocol, Huang et al. [79] found that the HLA-B + DR combination mismatch was an independent risk factor for grades II–III and III–IV acute GVHD in patients with chronic myeloid leukemia (CML). The gene discussed is HLA-B; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.